Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 4/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.39 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.39 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2221207 | 1.00 | ALOX5 (0.49) | ALOX5PTGS2SMN1; SMN2KDM4EMEN1 | |
| SCHEMBL13321375 | 1.00 | ALOX5 (0.49) | ALOX5PTGS2SMN1; SMN2KDM4EMEN1 | |
| SCHEMBL2221201 | 1.00 | ALOX5 (0.49) | ALOX5PTGS2SMN1; SMN2KDM4EMEN1 | |
| SCHEMBL29535850 | 0.94 | ALOX5 (0.51) | ALOX5PTGS2SMN1; SMN2KDM4EMEN1 | |
| SCHEMBL29785796 | 0.94 | ALOX5 (0.51) | ALOX5PTGS2SMN1; SMN2KDM4EMEN1 | |
| SCHEMBL3998710 | 0.94 | ALOX5 (0.51) | ALOX5PTGS2SMN1; SMN2KDM4EMEN1 | |
| SCHEMBL3998711 | 0.94 | ALOX5 (0.51) | ALOX5PTGS2SMN1; SMN2KDM4EMEN1 | |
| SCHEMBL23644507 | 0.93 | ALOX5 (0.46) | ALOX5PTGS2SMN1; SMN2KDM4EMEN1 | |
| SCHEMBL18489625 | 0.93 | ALOX5 (0.46) | ALOX5PTGS2SMN1; SMN2KDM4EMEN1 | |
| SCHEMBL3012002 | 0.92 | ALOX5 (0.50) | ALOX5PTGS2SMN1; SMN2KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122091405-A | Composite activated carbon and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| EP-4077489-B1 | POLYACRYLATE-BASED GRAFT COPOLYMER | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2026-03-11 | — | — | EP | claimed |
| US-12479946-B2 | Polyacrylate-based graft copolymer | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2025-11-25 | — | — | US | claimed |
| CN-119912332-A | Preparation method of high-optical-purity (S) -indoxacarb intermediate | 遵义医科大学 | 2025-05-02 | — | — | CN | claimed |
| WO-2025073644-A1 | NON-TOXIC LATENT POLYMERIZATION CATALYSTS FOR POLYURETHANES BASED ON TIN (IV) CHELATE COMPLEXES | TECH SYNT LTD (GB) | 2025-04-10 | — | — | WO | claimed |
| EP-4534577-A1 | NON-TOXIC LATENT POLYMERIZATION CATALYSTS FOR POLYURETHANES BASED ON TIN (IV) CHELATE COMPLEXES | Tech Synt Ltd (GB) | 2025-04-09 | — | — | EP | claimed |
| CN-119019285-A | Synthesis method of chiral alpha, alpha-disubstituted (N-hydroxy) amino acid compound | 山东第一医科大学(山东省医学科学院) | 2024-11-26 | — | — | CN | claimed |
| CN-116589376-A | Method for synthesizing chiral alpha- (N-hydroxy) amino acid amide under mild condition | 山东大学 | 2023-08-15 | — | — | CN | claimed |
| CN-116462626-A | Method for synthesizing carbazole N-H functionalized product based on Fe catalysis at normal temperature and normal pressure | 山东大学 | 2023-07-21 | — | — | CN | claimed |
| CN-116171858-A | Tissue culture and rapid propagation method of Mahalate iron orchid | 厦门市园林植物园 | 2023-05-30 | — | — | CN | claimed |
| US-20230026134-A1 | POLYACRYLATE-BASED GRAFT COPOLYMER | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2023-01-26 | — | — | US | claimed |
| EP-4077489-A1 | POLYACRYLATE-BASED GRAFT COPOLYMER | SABIC Global Technologies B.V. (NL) | 2022-10-26 | — | — | EP | claimed |
| CN-115094233-A | Method for efficiently utilizing full-size grade of iron selamestron | 抚顺新钢铁有限责任公司 | 2022-09-23 | — | — | CN | claimed |
| CN-114846056-A | Polyacrylate-based graft copolymers | SABIC环球技术有限责任公司 | 2022-08-02 | — | — | CN | claimed |
| CN-122091405-A | Composite activated carbon and preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| US-12629639-B2 | Spacer for a spiral wound membrane | EVOVE LTD (GB) | 2026-05-19 | — | — | US | disclosed |
| CN-119039215-B | Dimethylenepyridine bridged amino bisphenol oxy alkali metal complex and preparation method and application thereof | 华东理工大学 | 2026-05-15 | — | — | CN | disclosed |
| EP-3983470-A1 | PROCESS FOR THE CARBONYLATION OF EPOXIDES | Covestro Intellectual Property GmbH & Co. KG (DE) | 2022-04-20 | — | — | EP | disclosed |
| US-11299453-B2 | Compounds for use in the elimination of pluripotent stem cells | UNIVERSITÄT ZU KÖLN (DE) | 2022-04-12 | — | — | US | disclosed |
| US-11236197-B2 | Multi-block copolymers | IP2IPO INNOVATIONS LIMITED (GB) | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11299453-B2 | Compounds for use in the elimination of pluripotent stem cells | ALPG, RARB, RARG | ALOX5 3324/4885PTGS2 2537/4885SMN1; SMN2 1033/4885 |
| US-12629639-B2 | Spacer for a spiral wound membrane | AQP1, AQP3, AQP4 | ALOX5 4694/4885PTGS2 3126/4885SMN1; SMN2 3946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.